Diamond nanoparticles modity curcumin activity:<i>in vitro</i> studies on cancer and normal cells and <i>in ovo</i> studies on chicken embryo model by Strojny, Barbara et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Diamond nanoparticles modity curcumin activity
Strojny, Barbara; Grodzik, Marta; Sawosz, Ewa; Winnicka, Anna; Kurantowicz, Natalia;
Jaworski, Slawomir; Kutwin, Marta; Urbanska, Kaja; Hotowy, Anna; Wierzbicki, Mateusz;
Chwalibog, André
Published in:






Publisher's PDF, also known as Version of record
Citation for published version (APA):
Strojny, B., Grodzik, M., Sawosz, E., Winnicka, A., Kurantowicz, N., Jaworski, S., ... Chwalibog, A. (2016).
Diamond nanoparticles modity curcumin activity: in vitro studies on cancer and normal cells and in ovo studies
on chicken embryo model. P L o S One, 11(10), [e0164637]. https://doi.org/10.1371/journal.pone.0164637
Download date: 03. Feb. 2020
RESEARCH ARTICLE
DiamondNanoparticlesModify Curcumin
Activity: In Vitro Studies on Cancer and
Normal Cells and In Ovo Studies on Chicken
EmbryoModel
Barbara Strojny1, Marta Grodzik1, Ewa Sawosz1, Anna Winnicka2, Natalia Kurantowicz1,
Sławomir Jaworski1, Marta Kutwin1, Kaja Urbańska3, Anna Hotowy1,
Mateusz Wierzbicki1, Andre´ Chwalibog4*
1 Division of Nanobiotechnology, Faculty of Animal Sciences, Warsaw University of Life Sciences, 8
Ciszewskiego Str., 02–786, Warsaw, Poland, 2 Division of Histology and Embryology, Faculty of Veterinary
Medicine, Warsaw University of Life Sciences, 159 Nowoursynowska Str., 02–786, Warsaw, Poland,
3 Department of Pathology and Veterinary Diagnostics, Faculty of Veterinary Medicine, Warsaw University
of Life Sciences, 159 Nowoursynowska Str., 02–786, Warsaw, Poland, 4 Division of Nano-nutrition, Faculty




Curcumin has been studied broadly for its wide range of biological activities, including
anticancer properties. The major problem with curcumin is its poor bioavailability, which
can be improved by the addition of carriers, such as diamond nanoparticles (DN). They
are carbon allotropes, and are therefore biocompatible and easily taken up by cells. DN
are non-toxic and have antiangiogenic properties with potential applications in cancer
therapy. Their large surface makes them promising compounds in a drug delivery system
for bioactive agents, as DN create bio-complexes in a fast and simple process of self-
organisation. We investigated the cytotoxicity of such bio-complexes against liver cancer
cells and normal fibroblasts, revealing that conjugation of curcumin with DN significantly
improves its activity. The experiment performed in a chicken embryo model demonstrated
that neither curcumin nor DN nor bio-complexes affect embryo development, even though
DN can form deposits in tissues. Preliminary results confirmed the applicability of DN as
an efficient carrier of curcumin, which improves its performance against cancer cells in
vitro, yet is not toxic to an organism, which makes the bio-complex a promising anticancer
agent.
Introduction
Curcuminoids are primary compounds of turmeric, a broadly known spice that is mostly used
in India and the surrounding regions. Curcuminoids are derived from the perennial herb
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Curcuma longa, obtaining their intense orange-yellow colour from its rhizomes [1]. Curcumin
(Cur) [1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione], is a water-insoluble
diferuloylmethane (low molecular weight polyphenol) that was first isolated in 1815 by Vogel
[2] and chemically described in 1910 by Lampe and Milobedzka. It is regarded as the most
active compound of all turmeric fractions of curcuminoids [3,4].
There are hundreds of articles describing the biological activity of Cur and the number is
still growing. It is currently known that Cur interacts with numerous molecular targets, such as
transcription factors (e.g., NFκB, PPARγ, STAT family members, Notch), growth factors (e.g.,
HGF, PDGF, VEGF) and their receptors, cytokines (e.g., many interleukins,MIPa, TNFα),
enzymes (e.g., FASN, COX-2, 5-LOX, MMP family members) and genes regulating cell cycle
and apoptosis (e.g. Bax, beclin family members, caspases) [5]. The uses of Cur include the treat-
ment of various inflammatory diseases, rheumatism, swellings and abdominal problems as well
as wound healing [4]. Cur was also proved to have excellent antioxidant capacity, what was
demonstrated by chemical tests, as well as by in vitro assays performed on chicken red blood
cells [6]. Since the 1990s, interest in Cur has been focused on its potential as an anticancer
agent [7,8]. The major problem with Cur is its low bioavailability, which is due to its highly
hydrophobic character, poor absorption from the gut, limited distribution within body tissues,
low intrinsic activity and rapid excretion [2,9].
The inclusion of carriers can improve the bioavailability of Cur; hence, various Cur delivery
systems have been investigated, including liposomes, biodegradable polymers, dendrimers and
cellulose nanoparticles [10,11]. The application of nanotechnology for Cur usage has improved
its chemical stability, cellular uptake and antioxidant effects, prolonged blood circulation and
increased its anti-inflammatory and antitumor effects. Nanoparticles of diamond (DN), also
called nanodiamond, are one of the carbon allotropes; therefore, they are non-toxic, easily
taken up by cells and have a high biocompatibility [12–15]. Furthermore, DN have a large sur-
face area and a high absorption capacity [16]. DN can create bio-complexes with organic mole-
cules such as L-glutamine [17] in a fast and simple process, called self-organisation, which
makes DN a sufficient carrier of bioactive agents. Moreover, DN were demonstrated to have
antiangiogenic properties [18,19] and to inhibit tumour growth [20], as angiogenesis is one of
the major factors promoting tumour development. These features promote DN as a compo-
nent of drug-delivery systems for tumour treatment.
We hypothesised that Cur conjugated with DN could create a stable bio-complex, which
would improve Cur bioavailability and activity against tumour cells, being non-toxic and
highly biocompatible with an organism. In order to evaluate the cytotoxic effects of Cur, DN
and their bio-complexes against cancer and normal cells, we performed a series of assays on
the HepG2 liver cancer cell line and fibroblast primary cultures, including the evaluation of cell
viability, membrane integrity, morphology and apoptosis. The second part of the experiment
was performed on a chicken embryo to evaluate a potential toxicity of Cur, DN and their com-
plexes in a model organism.We evaluated the development, body and organ weights, blood
morphology and biochemistry as well as brain and liver histology.
Materials and Methods
Ethics statement
The experimental procedures were performed in accordance with Polish legal regulations con-
cerning experiments on animals (Dz. U. 05.33.289). The experimental protocols were approved
by the III Local Ethics Commission for Experimentation on Animals at Warsaw University of
Life Sciences, Poland.
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Hydrocolloids of curcumin, diamond nanoparticles and their bio-
complexes
Diamond nanoparticles, produced by the detonation method, purity>95%, were obtained
from Skyspring Nanomaterials (Houston, TX, USA). Curcumin was obtained from LKT Labo-
ratories Inc. (St. Paul, MN, USA).
Cur and DN were dissolved in ultra-high purity deionisedwater using sonication at a final
concentration of 500 mg/L. Bio-complexes of DN and curcumin at a ratio of 3:1 (3Cur:1DN
group) and a ratio of 1:3 (1Cur:3DN group) were obtained by the self-organisation process
using sonication for 30 min in an ultrasonic bath (Sonorex Super RK 514H, Bandelin Elec-
tronic, Germany). For experiments performed on cells, bio-complexes 3Cur:1DN and
1Cur:3DNwere diluted in culturingmedia to final concentrations 60 and 100 mg/L (which
corresponds to 15Cur:45DNmg/L, 45Cur:15DN, 25Cur:75DNmg/L and 75Cur:25DNmg/L),
whereas Cur and DN were diluted respective to their concentrations within bio-complexes (15,
25, 45 and 75 mg/L). Dilutions were prepared freshly before every test.
The shape and size of DN and bio-complexes were inspected by transmission electron
microscopy (JEM-2000EX; JOEL Ltd., Tokyo, Japan) at 200 keV. Zeta potential measurements
of hydrocolloids were carried out at 25°C by the laser dynamic scattering-electrophoretic
method with a Smoluchowski approximation using a ZetasizerNano-ZS90 (Malvern, Worces-
tershire, UK). Each measurement was repeated three times.
In vitro cell culture experiment
Cell cultures. The human hepatocarcinoma HepG2 cell line was obtained from the Amer-
ican Type Culture Collection (ATCC). The human fibroblast primary cell culture was isolated
from human skin by the Nalecz Institute of Biocyberneticsand Biomedical EngineeringPAS,
Warsaw, Poland.
HepG2 cells were maintained in Dulbecco’s Modified Eagle'sMedium (DMEM, Gibco™,
Thermo Scientific,Waltham, MA, USA) and human fibroblasts were maintained in Medium
106 (Gibco™).Media were supplemented with 10% foetal bovine serum (FBS, Gibco™), penicil-
lin (100 U/mL) and streptomycin (100 mg/mL) and cultures were maintained at 37°C in a 5%
CO2 and humidified atmosphere.
Viability assay. Cells were seeded on 96-well microplates (Nest Scientific, Rahway, NJ,
USA) at a density of 4 × 105 (HepG2) and 3 × 105 (human fibroblasts) in 100 μl of medium per
well. The next day, the mediumwas removed and replaced with fresh medium containing dilu-
tions of Cur and diamond nanoparticles (at concentrations of 15, 25, 45 and 75 mg/L) and
their complexes at concentrations of 60 and 100 mg/L (Cur15:DN45, Cur45:DN15, Cur25:
DN75 and Cur75:DN25). Cell viability was assessed after 24 h by MTT assay, where yellow sol-
uble tetrazolium salt is converted to purple formazan crystals.MTTwas dissolved in PBS (5
mg/ml) and 15 μl were added per well. After 3 h, solubilisation detergent (10% SDS, 0.01 M
HCl) was added (100 μl /well). Spectrophotometer readings were performed on the following
day at 570 nm on an Infinite1 200 PRO microplate reader with i-control™ Software (Tecan
Group Ltd., Männedorf, Germany). USA). Cell viability was expressed as the percentage of the
control group viability, which was 100%. Calculations were performed from the following for-
mula: ABStest- ABSblank) /(ABScontrol-ABSblank), where “ABS test” is the absorbance of wells
exposed to the treatment, “ABS control” is the absorbance of control wells, and “ABS blank” is the
absorbance of wells without cells, with media containing the respective treatment for each well.
Cellmembrane integrity assay. A lactate dehydrogenase (LDH) leakage test (LDH-based
In Vitro Toxicology Assay Kit, Sigma-Aldrich) was used to evaluate cell membrane integrity. If
the membrane is damaged, intracellular LDHmolecules are released into the culture medium
Nanodiamond and Curcumin
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and tetrazolium dye from the assay is stoichiometrically converted. Reduced nicotinamide ade-
nine dinucleotide (NADH+) is used for the detection of the converted dye.
HepG2 and human fibroblasts were seeded on 96-well plates and treated with Cur, DN and
their complexes as described above for the viability assay.
After 24 h of incubation, 25 μl of the culturemediumwas transferred to a clean, 96-well micro-
plate. A total of 50 μL of the lactate dehydrogenase assay mixture was added to each well. The
plate was covered and incubated for 20 min at room temperature. The remaining cells with 75 μl
of media were used for the calculation of cell number, which was performedby theMTT assay.
The absorbance for LDHmeasurements was recorded at 490 nm and background at 690
nm was subtracted. LDH leakage was as the percentage of the control group LDH release,
which was 100%. Calculations were performed from the following formula: ABStest/ABScontrol,
where “ABS test” is the absorbance of wells exposed to treatment, “ABS control” is the absorbance
of the control wells. Results were then normalized to the number of cells calculated by the
MTT assay by dividing the % of LDH leakage by the % of living cells for each well.
Cell death type. The type of death was evaluated by propidium iodide (PI) staining and
annexin V (AnnV) assay (Thermo Scientific,Waltham, MA USA), where PI is a fluorescent
dye incorporated into nucleic acids of dead and disrupted cells and annexin V conjugated to
the fluorescent marker Alexa Fluor 488 binds specifically to phosphatidylserine, which is
exposed on the external surface of the cell membrane during apoptosis. PI-positive cells are
considered necrotic, PI/AnnV-positive cells as late apoptotic and AnnV-positive cells as apo-
ptotic. Live cells remain unstained.
Cells were seeded on 12-well plates (Nest Scientific) at a density of 4 × 105 (HepG2) and
5 × 104 (human fibroblasts) in 1 ml per well. The next day, the mediumwas replaced with
fresh medium containing dilutions of Cur and DN nanoparticles at concentrations of 15 and
45 mg/L, and their complexes at concentrations of 60 mg/L (Cur 15:DN45, Cur45:DN15).
After 24 h, the mediumwas removed and the cells were washed with PBS. The staining proce-
dure was performed according to the manufacturer's protocol. Readings were performedwith
BD FACSCalibur™ cytometer (BectonDickinson, Franklin Lakes, NJ, USA). Eight thousand
events were recorded for each sample. Plots were generated using Flowing Software 2.5.1
(Perttu Terho, Turku, Finland).
Cellmorphology. Cells were seeded on 12-well plates (Nest Scientific) at a density of
4 × 105 (HepG2) and 5 × 104 (human fibroblasts) in 1 ml per well. The next day, the medium
was replaced with fresh medium containing dilutions of Cur and DN nanoparticles at concen-
trations 50 mg/L, and their complexes at concentrations 100 mg/L (Cur25:DN75, Cur75:
DN25). After 24 h of incubation (37°C, 5% CO2), the mediumwas removed and the cells were
washed twice with PBS. One millilitre of May-Grünwald stain was added per well and after 3
min, it was diluted with an equal amount of PBS. After 3 min, the stain was replaced with 1 ml
of Giemsa stain (diluted 1:20 in distilledwater). After 30 min, the stain was removed and the
cells were washed thoroughly with distilledwater. The evaluation was performed under a
microscope connected to a digital camera.
In ovo chicken embryo experiment
Design of the experiment. The fertilized eggs (Gallus gallus, strain Hubbard) were sup-
plied by a commercial, local hatchery (Marylka, Poland). Fertilized eggs (150) were divided
into six groups as follows: without injection (Control), injected with phosphate-buffered saline
(Placebo), injected with hydrocolloid of Cur (Cur group), injected with hydrocolloid of dia-
mond nanoparticles (DN group) and injected with hydrocolloid of Cur with diamond nano-
particles at a ratio of 3:1 (3Cur:1 DN group) and at a ratio of 1:3 (1Cur:3DN group).
Nanodiamond and Curcumin
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Embryonic day 0 (E0) was designated as the day when the eggs were placed into the incuba-
tor. The experimental solution was given in ovo, into the albumen on the E0 day of incubation,
by injection of 0.3 ml of solution, using a sterile insulin syringe. After the injection, the holes
were sealedwith sterile tape and the eggs were then incubated for 20 days under standard con-
ditions (temperature 37.8°C, humidity 55%, turned once per hour during the first 18 days, and
from day 19 at a temperature of 37°C and humidity 60%).
At day 20 of incubation, embryomortality was evaluated and the developmental status of
chicken embryos was compared with the stages of development describedby Hamburger and
Hamilton [21]. The embryos and organs (liver, brain, spleen and heart) were weighed and
blood samples were collected from neck blood vessels after decapitation.
Bloodmorphology. A droplet of each blood sample was used to prepare blood smears,
stained by the Pappenheim methodwithMay-Grünwald and Giemsa solutions (Sigma-Aldrich).
Bloodmorphologywas recorded under a light microscope (DM750; LeicaMicrosystems GmbH,
Wetzlar, Germany) connected to a digital camera, using LAS EZ v 2.0 software (Leica). Total
white blood cells were counted and shown as the % of all counted cells in blood samples.
Blood serumbiochemistry. Blood samples were centrifuged (3000 rpm, 15 min; Thermo
Fisher Scientific,Waltham, MA, USA) and activities of alanine aminotransferase (ALT) and
asparagine aminotransferase (AST) were measured. ALT and AST were examined using the
Vitros DT 60 II chemistry system (Johnson and Johnson, New Brunswick, NJ, USA).
Brain and liver histology. Sampled chicken brains and livers were fixed in 10% buffered
formaldehyde, pH 7.2 (Sigma-Aldrich), then dehydrated in a graded series of ethanols, embedded
in paraffin (Paraplast, Sigma-Aldrich), cut into sections (5 μm) with a microtome (Leica,Nus-
sloch, Germany) and stained using haematoxylin (POCHS.A, Gliwice, Poland) and eosin (BDH
Laboratory Supplies, Poole, Dorset, United Kingdom).Morphologywas evaluated using a light
microscope (DM750; Leica) connected to a digital camera and a computer analysis system (Leica).
Statistical analysis. The data are shown as a mean and standard error of the mean (SEM)
or standard deviation (SD). Statistical analysis of data was carried out using one-factorial anal-
ysis of variance (ANOVA) with Duncan’s post-test to determine the differences between the
groups for in ovo results or two-factorial ANOVA for in vitro results with Bonferroni’s post-
tests, where DN and Cur were factors. Effects with P-values<0.05 were considered significant.
The analysis was performed using Statgraphics Centurion ver. XV software (Warrenton,
VA, USA). Plots for cells viability and LDH leakage were created using GraphPad Prism 5.0
(La Jolla, CA, USA).
Results
Bio-complex analysis
TEM examination confirmed the formation of complexes betweenCur and DN. The average
size of a single DN was from 2 to 5 nm (Fig 1A). The size of Cur particles was not defined
because they created a cloud-shaped structure (Fig 1B). The size of bio-complexes of Cur and
DN could not be precisely defined; nevertheless, it was estimated to be in the range of 10 to 100
nm (Fig 1C). The mean zeta potential values of Cur, DN and bio-complexes (3Cur:1DN and
1Cur:3DN) were negative, indicating the stability of colloids: -29.2 mV, -37.3 mV, -31.1 mV
and -28.7 mV, respectively for Cur, DN, 3Cur:1DN and 1Cur:3DN-37.3mV in DN solution to
-28.3 mV in 1Cur:3DN solution.
In vitro cell culture experiment
Cell viability. Cur affected cell viability in both the HepG2 cell line and fibroblast cultures,
which was demonstrated by decreasedmitochondrial activity (Figs 2 and 3). Moreover, the
Nanodiamond and Curcumin
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linking of Cur to DN decreased cell viability in comparison with Cur alone in the same concen-
tration as in bio-complexes. Among them, bio-complexes with the ratio 1Cur:3DN seemed to
be the most effective and two-way ANOVA showed significant interaction betweenCur and
DN for this ratio in fibroblasts (Fig 3). DN alone impacted the viability of fibroblasts, but not
that of HepG2; however, the effect on fibroblasts was less prominent than that of Cur as part of
bio-complexes. The half maximal inhibitory concentration (IC50) of Cur was calculated to be
between 25.5 and 31.9 mg/L for the HepG2 cell line and 46.8 mg/L for fibroblasts.
Cellmembrane integrity. Cur and Cur:DN bio-complexes affected cell membrane integ-
rity in HepG2 cells, which led to significant leakage of LDH (Figs 4 and 5). For fibroblasts, the
same effect was recorded only in cells treated with bio-complexes, confirming the interaction
betweenDN and Cur. DN did not disrupt cell membranes, neither in HepG2 nor in fibroblasts,
except at the concentration of 75 mg/L in fibroblasts, where the leakage was noticeable.
Cell death type. The assay we used allowed us to detect one of the earliest stages of apopto-
sis, which is phosphatidylserine externalization. The % of necrotic cells in all samples was not
significant in contrast to that of apoptotic cells (Figs 6 and 7). In both HepG2 cells and fibro-
blasts, Cur induced programmed cell death, alone and within bio-complexes (Table 1). The lat-
ter effect was especially enhanced in fibroblasts.
Cellmorphology. Cell morphology confirmed the assay results: the number of cells
treated with Cur:DN bio-complexes was diminished, which was clearly visible in the HepG2
line (Fig 8). Moreover, cells showed a tendency to agglomerate: they were shrunken and lost
their shape. In wells where cells were treated with DN and Cur:DN, deposits of DN were visible
Fig 1. TEM examination of Cur (A), DN (B) and a bio-complex of Cur:DN in a ratio of 1:3 (C).
doi:10.1371/journal.pone.0164637.g001
Fig 2. HepG2 cell viability measured by mitochondrial activity depletion after DN, Cur and DN:Cur bio-
complexes treatment, separately for each of the used bio-complexes the DN and Cur concentrations in
each of the bio-complexes were 15, 25, 45 and 75, defining the concentrations in mg/L: A–Cur15:DN45
(P < 0.0001 for Cur effect, P = < 0.0001 for DN effect, P = 0.4813 for Cur x DN effect); B–Cur25:DN75 (P < 0.0001
for Cur effect, P = 0.0001 for DN effect, P = 0.3422 for Cur x DN effect); C–Cur45:DN15 (P < 0.0001 for Cur effect,
P = 0.0043 for DN effect, P = 0.1610 for Cur x DN effect); D–Cur75:DN25 (P < 0.0001 for Cur effect, P = 0.1207 for
DN effect, P = 0.0722 for Cur x DN effect). Graphs show mean ± SD, *** P <0.001, for Cur effect by Bonferroni
post-tests following two-way ANOVA with Cur and DN factors.
doi:10.1371/journal.pone.0164637.g002
Nanodiamond and Curcumin
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across the whole well. Interestingly, fibroblasts treated with DN seemed to formmore regular
structures than control cells (Fig 9).
Mortality, growth and development of chicken embryos. The administration of Cur, DN
and their bio-complexes slightly affected the mortality of embryos, which ranged from 8% in
the Control and 3Cur:1DN groups to 15% in the Cur group (Table 2). In all groups, chicken
embryos developed normally without abnormalities, in accordance with the Hamburger and
Hamilton stages[21]. At day 20 of incubation (stages 44-45), chickens were completely devel-
oped and yolk sacs were partly enclosed in the body cavity. Statistical analysis of embryo weight
showed no significant difference between groups; similarly, the brain, liver and spleen weights
were not significantly different. However, the weight of the heart was significantly lower in DN
and Cur:DN groups than in the control group.
Bloodmorphologyand biochemical indices. The blood smears from the Control, Pla-
cebo and treated groups did not show symptoms of inflammation and blood cell deformation
(Fig 10). However, in the Cur group, the number of white blood cells was significantly higher
than in the other groups.
There was a tendency toward increasedALT and AST levels in the DN group compared
with the other groups (Table 3); however, none of the biochemical indices measured in the
blood sera showed significant effects of the treatments. According to Mazurkiewicz [22], all
results of biochemical indices, except for the levels of ALT in the DN and Placebo groups, were
within the reference range.
Fig 3. Fibroblast cell viability measured by mitochondrial activity depletion after DN, Cur and DN:Cur bio-
complexes treatment, separately for each of the used bio-complexes the DN and Cur concentrations in
each of the bio-complex were 15, 25, 45 and 75, defining the concentrations in mg/L: A–Cur15:DN45
(P < 0.0001 for Cur effect, P = < 0.0001 for DN effect, P = 0.1568 for Cur x DN effect); B–Cur25:DN75 (P < 0.0001
for Cur effect, P < 0.0001 for DN effect, P < 0.0001 for Cur x DN effect); C–Cur45:DN15 (P < 0.0001 for Cur effect,
P = < 0.0001 for DN effect, P = 0.0615 for Cur x DN effect); D–Cur75:DN25 (P < 0.0001 for Cur effect, P = < 0.0001
for DN effect, P = 0.0495 for Cur x DN effect). Graphs show mean ± SD, ** P <0.01, *** P <0.001, for Cur effect
by Bonferroni post-tests following two-way ANOVA with Cur and DN factors and #P <0.05, ###P <0.001 for the
Cur x DN interaction.
doi:10.1371/journal.pone.0164637.g003
Fig 4. HepG2 membrane integrity measured by LDH leakage after DN, Cur and DN:Cur bio-complexes
treatment, separately for each of the used bio-complexs the DN and Cur concentrations in each of the bio-
complexes were 15, 25, 45 and 75, defining the concentrations in mg/L: A–Cur15:DN45 (P < 0.0001 for Cur
effect, P = 0.0667 for DN effect, P = 0.4338 for Cur x DN effect); B–Cur25:DN75 (P < 0.0001 for Cur effect,
P = 0.0004 for DN effect, P = 0.0024 for Cur x DN effect); C–Cur45:DN15 (P < 0.0001 for Cur effect, P = 0.1844 for
DN effect, P = 0.8649 for Cur x DN effect); D–Cur75:DN25 (P < 0.0001 for Cur effect, P = 0.4403 for DN effect,
P = 0.3246 for Cur x DN effect). Graphs show mean ± SD, ** P <0.01, *** P <0.001, for Cur effect by Bonferroni
post-tests following two-way ANOVA with Cur and DN factors and ###P <0.001 for the Cur x DN interaction.
doi:10.1371/journal.pone.0164637.g004
Nanodiamond and Curcumin
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Brain and liver histology. There were no noticeable changes or pathological features of
brain microstructures in the inner part of the cerebral cortex in any of the groups. The average
number of neural cells (area counted: 3,500 μm2) were not significantly different between the
groups (Table 4). However, in the DN group, the outermost part of neuropilin was slightly
thinner than in the control group (Fig 11) and some necrotic-like neurons were present. Silver-
gray, round-shaped particles were observed in the outer part of the brain (Fig 11D).
No differences in liver histology were observedbetween the groups. In all groups, the abun-
dance of fat droplets in hepatocytes was noticeable, which was due to glycogen accumulation
since the 7th day of embryogenesis. In all groups, small populations of heterophils were present
in the proximity of wider blood vessels and hepatic sinuses (Fig 12). This feature is not
regarded as pathological, because of its presence in both Placebo and Control groups, at the
same level as in the other groups. Along with the heterophils, darker and thicker cells are pres-
ent, which were recognized as primary hematopoietic cells. In chicken, hematopoietic cells are
Fig 5. Fibroblast membrane integrity measured by LDH leakage after DN, Cur and DN:Cur bio-complexes
treatment, separately for each of the used bio-complex the DN and Cur concentrations in each of the bio-
complexes were 15, 25, 45 and 75, defining the concentrations in mg/L: A–Cur15:DN45 (P = 0.0336 for Cur
effect, P = 0.0171 for DN effect, P = 0.0952 for Cur x DN effect); B–Cur25:DN75 (P = 0.0136 for Cur effect,
P = 0.0003 for DN effect, P = 0.7073 for Cur x DN effect); C–Cur45:DN15 (P < 0.0001 for Cur effect, P = 0.0001 for
DN effect, P = 0.0019 for Cur x DN effect); D–Cur75:DN25 (P < 0.0001 for Cur effect, P < 0.0001 for DN effect,
P = 0.0001 for Cur x DN effect). Graphs show mean ± SD, * P <0.05, ** P <0.01, *** P <0.001, for Cur effect by
Bonferroni post-tests following two-way ANOVA with Cur and DN factors and ##P <0.01, ###P <0.001 for the Cur
x DN interaction.
doi:10.1371/journal.pone.0164637.g005
Fig 6. Dot blot/scatter diagrams of PI/AnnV staining of HepG2 cells treated with curcumin (Cur), diamond
nanoparticles (DN) and their bio-complexes (Cur:DN) at concentrations of 15 and 45 mg/L. The transition of
cells to AnnV quadrants visible for Cur and bio-complex-treated cells.
doi:10.1371/journal.pone.0164637.g006
Nanodiamond and Curcumin
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moving toward the liver just before hatching and are usually abundant around the sinuses dur-
ing this period.
Discussion
In our experiment, we investigated the influence of Cur, DN and their bio-complexes on in
vitro cell cultures and a chicken embryomodel. By employing the cancerous cell line HepG2
and primary cell culture of normal fibroblasts, we expected differing responses to treatment
with Cur and DN.
Cur has been used widely for centuries as a spice and is known to be non-toxic to humans
and animals. It has been investigated mainly as an anti-inflammatory and chemopreventive
agent, and numerous molecular targets have been found. Among them are genes involved in
programmed cell death pathways. Thus, Cur has an enormous potential to eliminate cancer
cells in vitro [3]. However, the application in in vivo systems remains the great challenge, as the
bioavailability of Cur is poor, owing to its strong hydrophobic character [9].
In the present work, we show that Cur induces apoptotic death in cancer cells, but not in
normal fibroblasts (Table 1; Figs 6 and 7). The proapoptotic effect of Cur against HepG2 cancer
line was demonstrated previously. It is known that FAS, one of the target genes, that partici-
pates in fatty acid metabolism and lipogenesis, is downregulated by Cur and its intracellular
protein activity is also inhibited, leading to the death of liver cancer cells [23]. Another pro-
posedmechanism is the promotion of superoxide production by depletion of glutathione and
Bcl-2 downregulation [24]. It should be noted that in our studies, the IC50 for HepG2 cells was
calculated to be between 25.5 and 31.9 mg/L, which might seem relatively high to some authors
Fig 7. Dot blot/scatter diagrams of PI/AnnV staining of fibroblasts treated with curcumin (Cur), diamond
nanoparticles (DN) and their bio-complexes (Cur:DN) at concentrations of 15 and 45 mg/L. The transition of
cells to AnnV quadrants visible for bio-complex-treated cells.
doi:10.1371/journal.pone.0164637.g007
Table 1. Total % of apoptotic cells (both early and late apoptosis) in HepG2 cells and fibroblasts (Fib) treated with curcumin (Cur), diamond nano-
particles (DN) and their bio-complexes (Cur:DN) at concentrations of 15 and 45 mg/L.
Control Cur15 Cur45 DN15 DN45 Cur15:DN45 Cur45:DN15
HepG2 9.43 59.34 75.23 59.30 51.54 58.19 55.04
Fib 14.65 13.69 22.77 6.81 10.72 33.49 41.85
doi:10.1371/journal.pone.0164637.t001
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Fig 8. HepG2 cell morphology. Control (A), Cur45 (B), DN45 (C), Cur75:DN25 (D), Cur25:DN75 (E). DN
visible on the surface of wells (C–E). Scale bar indicates 200 μm.
doi:10.1371/journal.pone.0164637.g008
Fig 9. Fibroblast cell morphology. Control (A), Cur45 (B), DN45 (C), Cur75:DN25 (D), Cur25:DN75 (E). Scale
bar indicates 500 μm.
doi:10.1371/journal.pone.0164637.g009
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[23,25]. However, most of the studies are based on solubilisation of Cur in organic solvents,
such as DMSO, and then dilution in culturingmedia. Employing such chemicals for in vivo
application might be controversial. Since the aim of the experiment was to increase the bio-
availability of Cur in a hydrophilic environment, we did not use any solvents–Cur was only
well dispersed in water by sonication.
Making a complex of Cur and a nanocarriermay improve Cur activity in a living organism.
In the present experiment, we obtained bio-complexes of DN and Cur, which were proven to
be stable, using Zeta potential measurement and TEM examination (Fig 1). DN can serve as a
Table 2. The mortality, abnormalities and body and organ weights in 20-day-old chicken embryos after in ovo injection of curcumin (Cur), dia-
mond nanoparticles (DN) and their bio-complexes (3Cur:1DN; 1Cur:3DN).
Groups ANOVA
Control Placebo Cur DN 3Cur:1DN 1Cur:3DN SEM P-Value
Mortality [%] 8 10 15 9 8 11 - -
Embryo body mass [g]* 48.6 46.6 49.2 47.9 46.9 47.9 1.25 NS
Liver [g/100g body mass] 2.321 2.115 2.225 2.254 2.145 2.587 0.0927 NS
Brain [g/100g body mass] 2.651 2.758 2.614 2.514 2.801 2.721 0.1175 NS
Spleen [g/100g body mass] 0.035 0.037 0.036 0.036 0.033 0.035 0.0021 NS
Heart [g/100g body mass] 0.768a 0.743c 0.732c 0.712b 0.723b 0.713b 0.0372 0.04
abc values within rows with different superscripts are significantly different
NS statistically not significant
*Embryos weighed with the yolk sac
doi:10.1371/journal.pone.0164637.t002
Fig 10. Images of stained chicken blood smears. Groups: Control (A), Placebo (B), Cur (C), DN (D),
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potential carrier of bioactive compounds such as curcumin.DN have a large surface area and a
high absorption capacity [16], therefore, they can create bio-complexes with organic molecules
such as L-glutamine [17]. Being one of the carbon allotropes, they are considered non-toxic
and may be easily taken up by cells.
This was confirmed by the set of tests performed on in vitro cells of the HepG2 line and
fibroblast culture, where the activity of Cur was increasedwhen in a complex with DN. In the
bio-complexes with DN, Cur showed higher activity than Cur itself, even in higher doses, e.g.,
in a Cur15:DN45 complex we observed lower viability of cells (Fig 2) and higher leakage of
LDH (Fig 4) than in cells treated with Cur at 25-75 mg/L concentrations. There was also the
loss of proper morphology (Fig 8) and enhanced phosphatidylserine externalization (Fig 7),
which is a feature of programmed cell death. Wang et al. [25] reported that loss of proper mor-
phology after Cur treatment in this cell line is caused by the disruption of mitochondrial mem-
brane potential and the disturbance of intracellular Ca2+ concentration. At the same time,
HepG2 cells remained insensitive to bare DN (Figs 2, 4 and 6), as previously shown in other
hepatic cancer cell lines [26], whereas, in fibroblasts, only a small effect was observed (Figs 3, 5
and 7). Interestingly, the assembly of Cur and DN seemed to have a negative impact on fibro-
blasts, indicating the interaction betweenCur and DN (Table 1; Figs 5 and 7). Lundvig et al.
[27] performed experiments on a similar primary culture of fibroblasts, showing that Cur
indeed induced the apoptotic response by increasing reactive oxygen species production.
Moreover, Zhou et al. [28] proved that Cur inhibited the proliferation of normal fibroblasts,
not only in vitro but also in vivo in a mouse model of renal fibrosis, suggesting a PPARγ-depen-
dent mechanism. The same receptor was recognized as a key molecule in angiogenic signal
transduction in hepatic stellate cells [29], where Cur inducing its expression prevents hepatic
fibrogenesis in vitro [30].
In the next step of the experiment, we decided to examine Cur, DN and their complexes on
a living, tissue-organized organism. The investigation was carried out on the chicken embryo,
which is a recognized animal model used in biocompatibility and toxicology trials and develop-
mental studies employing nanoparticles and nanostructures [17,31–33]. Because it has a rapid
growth rate and its development is well described, the model is relatively fast and reproducible.
In our previous experiments, we have demonstrated that DN did not cause acute toxicity or
increasemortality or affect the basic parameters of growth and development of embryos [17].
Table 3. Mean number of total white blood cells shown as a % of all counted cells in embryo blood samples from 20-day-old embryos after in ovo
injection of curcumin (Cur), diamond nanoparticles (DN) and their bio-complexes 3Cur:1DN and 1Cur:3DN.
Reference values Group ANOVA
Control Placebo Cur DN 3Cur: 1DN 1Cur: 3DN SEM P-Value
% WBC of total cell count 0.7a 0.9a 2.6b 1.7a 1.1a 1.5a 0.517 0.0007
AST [U/L] 90–226 71.25 94.24 86.21 90.01 80.09 78.35 18.365 NS
ALT [U/L] 9–14 10.25 11.75 11.75 18.32 15.32 14.95 4.253 NS
ab values within rows with different superscripts are significantly different
doi:10.1371/journal.pone.0164637.t003
Table 4. Mean number of neural cells counted in a total area of 3,500 μm2 in 20-day-old chicken embryos after in ovo injection of curcumin (Cur),
diamond nanoparticles (DN) and their bio-complexes 3Cur: 1DN and 1Cur: 3DN.
Group ANOVA
Control Placebo Cur DN 3Cur: 1DN 1Cur: 3DN SEM P-Value
Number of neural cells 471 506 511 487 495 521 14.2 NS
doi:10.1371/journal.pone.0164637.t004
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However, it was shown that DN decrease heart mass and reduce the number of blood vessels in
both the developing chorioallantoic membrane of chicken and in glioblastomamultiforme
tumour in in ovo experiments [19,20]. Moreover, DN were proven to inhibit the expression of
bFGF, the factor controlling heart development [18]. A similar effect was observed in the pres-
ent experiment: after treatment with DN and DN:Cur, the weight of the embryonic heart was
reduced, compared with that of the control group (Table 2). It has been investigated that other
carbon nanomaterials can also affect the microvasculature development, including microwave-
radiofrequency carbon allotrope [20] or multiwalled carbon nanotubes, which decreased the
formation of new vessels, while fullerenes C60 or graphene nanosheets were promoting the
process [19]. Ema et al. [34] also reported the negative impact of both single- and multiwalled
carbon nanotubes on foetuses of nanotubes treated mice, including malformation of the vascu-
lature in placentas. Similarly, Qi et. al [35] described reduced number of blood vessels in
murine placentas after 99mTc-labelled oxidisedmultiwalled carbon nanotubes treatment in
pregnant mice. Another carbon nanomaterial, pristine graphene did not affect the develop-
ment of the embryos or their hearts in the experiment on chicken embryos, although it
increased the mortality ratio [33].
Furthermore, the treatments caused a deposition of unidentified particles in the outer layer
of the cerebral cortex (Fig 11). Round-shaped particles observed in the outer part of brains in
the DN group could be aggregates, but they were observedonly in the outermost layer of the
brain tissue, beyond the ependyma (Fig 11D).
Yuan et al. [36] reported residues of DN in mouse bodies after a single intravenous injec-
tion. DN accumulatedmostly in the liver and at a lower rate in the lungs. Very low uptake was
noted in other tissues, including the brain. After a longer exposure (28 days) the level of accu-
mulated DN was stable both in the liver and the lungs. In the cited work, the size of a single
Fig 11. Brain histology of chicken embryo. Groups: Control (A), Placebo (B), Cur (C), DN (D), 3Cur:1DN (E),
1Cur:3DN (F). Silver-grey particles were observed in the DN group (black arrows) and single necrotic-like
neurons (white arrows). Scale bar indicates 100 μm.
doi:10.1371/journal.pone.0164637.g011
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particle was approximately 50 nm, whereas the DN used in our studies ranged from 2 to 9 nm.
It is known that the size of nanoparticles can influence their properties; therefore, comparisons
between studies should be made carefully. Zhang et al. [37] employed DN of similar size (2 to
10 nm), radiolabelledwith rhenium, and investigated their biodistribution and toxicity to mice
after intratracheal instillation. They reported an accumulation of DN, mainly in the lungs and
a redistribution in the other organs (spleen, liver and bones). Histology of the organs showed
no abnormalities; however, histopathological analysis of lung tissues revealed inflammatory
responses characterized by the accumulation of neutrophils and macrophages. In our experi-
ment, the outer layer of neuropilin in the DN group was thinner than in the control group and
some neuron cells showed features of necrosis: their nuclei were smeared and the cytoplasm
was eosinophilic stained. However, the changes were not abundant, and the inner part of the
brain was not different from that of the other groups. The formation of deposits in the brain
may represent DN accumulation at the beginning of embryogenesis because the neural tube is
the first structure to be developed [21].
In our previous works, we investigated the biocompatibility of DN inWistar rats [15],
knowing that DN can form large agglomerates in tissues [14]. Even though DN were adminis-
trated for four weeks and the agglomerates were present within a body cavity for three months,
we noticed no major negative impact on the animals' health, neither did we observe a disrup-
tion of the oxidative state of the liver tissue nor a potential inflammatory state. Similarly, in the
current experiment, we did not observe any signs of DN or DN:Cur accumulation in the
chicken embryo liver. No pathological changes were observed in the liver histology (Fig 12).
Not many studies have been performed concerning embryotoxicity of Cur. Studies on the
reproduction of Wistar rats supplemented with Cur showed no negative effects, neither on
Fig 12. Liver histology of chicken embryos. Groups: Control (A), Placebo (B), Cur (C), DN (D), 3Cur:1DN
(E), 1Cur:3DN (F). Heterophils and primary hematopoietic cells were present in the proximity of wider
blood vesicles (black arrows). Scale bar indicates 100 μm.
doi:10.1371/journal.pone.0164637.g012
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parental animals nor on the offspring [38]. On the other hand, Wu et al. [39] performed studies
on zebrafish embryos and larvae and their results suggest that Cur negatively affects embryo-
genesis, causing numerous defects. Similarly, Chen et al. [40] reported that curcumin treatment
caused apoptosis induction in mouse blastocysts in vitro. On the contrary, our results showed
no negative effect on chicken embryo development.
The bio-complexes of DN and Cur did not affect embryo development, suggesting that the
DN and Cur complexes may have different properties from those of raw compounds. It is pos-
sible that DN and Cur create a new compound, the properties of which are not a simple sum of
the properties of DN and Cur. Interestingly, no deposits were observed in the brains, where
DN were in a complex with Cur (Fig 11E–11F), which could indicate a specific interaction
betweenDN and Cur and their active surfaces. On its own, DN tends to clump together due to
its high surface energy [41]. Cur may attach to the reactive surface of DN, inhibiting the forma-
tion of the deposits during embryogenesis. All of the results from the DN and Cur groups were
closer to those of the control group than to those of the DN group, confirming that the interac-
tion between the compounds favours embryo development and that the bio-complexes are bio-
compatible. These observations support an argument for employing DN as a carrier for Cur or
other active substances, which could prevent DN from clumping together, helping to disperse
the particles properly in solutions, i.e., during the application of a drug based on DN. Com-
plexes containing DN can be employed as a carrier for site-targeted therapies such as tumour
treatment, promoting the accumulation and slow release of an active agent such as Cur in a
tissue.
In our experiment, Cur was proven to induce apoptosis in liver cancer cells, which was sig-
nificantly increasedwhen Cur was in a complex with DN, indicating improved bioavailability
of Cur. Even though such bio-complexes slightly affected normal cells in vitro, the effect was
different from that seen in cancer cells and no harmful effects on the chicken embryomodel
were recorded. This favours the present bio-complex to be employed for liver cancer therapies,
ensuring selective action against cancer cells without systemic harmful effects on normal tis-
sues. The use of DN also has another benefit: DN itself may decrease the development of
tumours, due to their antiangiogenic properties, which were investigated previously [18,19].
Conclusions
In vitro experiments on HepG2 liver cancer cells confirmed the proapoptotic activity of Cur in
cancer cells, but not in normal fibroblasts. The effect was significantly enhanced when Cur was
in complexes with DN, indicating an improvement of Cur bioavailability in a hydrophilic envi-
ronment. In ovo administration of a high concentration of hydrocolloids of DN, Cur and bio-
complexes did not affect the development of chicken embryos, confirming their biocompatibil-
ity and selective Cur activity. Bio-complexes of DN and Cur are non-toxic, stable and biocom-
patible, which suggests their potential applicability in a drug delivery system such as cancer
treatment without harmful effect on healthy tissues.
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